PubMed · 16549599
Virus-specific CD4+ T cells: ready for direct attack.
Abstract
CD4+ T cells are classically thought to orchestrate adaptive immune responses. But recent studies demonstrate that they can also kill infected cells directly. A new paper shows that highly efficient processing of Epstein Barr virus (EBV) glycoproteins for presentation on MHC class II makes virus-transformed B cells susceptible to lysis by CD4+ T cells. Thus, antiviral vaccines should aim to stimulate both helper and cytolytic CD4+ T cells.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kevin N Heller, Cagan Gurer, Christian Münz. 2006-03-20. Virus-specific CD4+ T cells: ready for direct attack.. https://doi.org/10.1084/jem.20060215
Cite the original work for its findings. Save a collection to share your selection of sources.